160 related articles for article (PubMed ID: 8383921)
1. Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions.
Sörgel F; Kinzig M
Am J Med; 1993 Mar; 94(3A):56S-69S. PubMed ID: 8383921
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of gyrase inhibitors, Part 1: Basic chemistry and gastrointestinal disposition.
Sörgel F; Kinzig M
Am J Med; 1993 Mar; 94(3A):44S-55S. PubMed ID: 8383920
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics and tissue penetration of the fluoroquinolones.
Bergeron MG
Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
[TBL] [Abstract][Full Text] [Related]
4. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
[TBL] [Abstract][Full Text] [Related]
5. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of gyrase inhibitors.
Sörgel F
Rev Infect Dis; 1989; 11 Suppl 5():S1119-29. PubMed ID: 2549606
[TBL] [Abstract][Full Text] [Related]
7. Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.
Takei M; Fukuda H; Kishii R; Hosaka M
Antimicrob Agents Chemother; 2001 Dec; 45(12):3544-7. PubMed ID: 11709337
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of the newer antibacterial 4-quinolones.
Neuman M
Clin Pharmacokinet; 1988 Feb; 14(2):96-121. PubMed ID: 3282749
[TBL] [Abstract][Full Text] [Related]
9. Gyrase-inhibitors impair caffeine elimination in man.
Staib AH; Harder S; Mieke S; Beer C; Stille W; Shah P
Methods Find Exp Clin Pharmacol; 1987 Mar; 9(3):193-8. PubMed ID: 3037212
[No Abstract] [Full Text] [Related]
10. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
Fuhr U; Strobl G; Manaut F; Anders EM; Sörgel F; Lopez-de-Brinas E; Chu DT; Pernet AG; Mahr G; Sanz F
Mol Pharmacol; 1993 Feb; 43(2):191-9. PubMed ID: 8429824
[TBL] [Abstract][Full Text] [Related]
11. [How well do gyrase inhibitors work? The pharmacokinetics of quinolones].
Sörgel F; Bulitta J; Kinzig-Schippers M
Pharm Unserer Zeit; 2001; 30(5):418-27. PubMed ID: 11575179
[No Abstract] [Full Text] [Related]
12. Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.
Shiga T; Hashiguchi M; Urae A; Kasanuki H; Rikihisa T
Clin Pharmacol Ther; 2000 Mar; 67(3):222-8. PubMed ID: 10741624
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of drug metabolism by quinolone antibiotics.
Edwards DJ; Bowles SK; Svensson CK; Rybak MJ
Clin Pharmacokinet; 1988 Sep; 15(3):194-204. PubMed ID: 3052987
[TBL] [Abstract][Full Text] [Related]
14. [Quinolones. Gyrase inhibitors].
Höffler D
Internist (Berl); 1994 May; 35(5):484-9. PubMed ID: 8021119
[No Abstract] [Full Text] [Related]
15. Molecular mechanisms of drug inhibition of DNA gyrase.
Lewis RJ; Tsai FT; Wigley DB
Bioessays; 1996 Aug; 18(8):661-71. PubMed ID: 8760340
[TBL] [Abstract][Full Text] [Related]
16. Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors.
Cihlar T; Ray AS; Laflamme G; Vela JE; Tong L; Fuller MD; Roy A; Rhodes GR
Antivir Ther; 2007; 12(2):267-72. PubMed ID: 17503669
[TBL] [Abstract][Full Text] [Related]
17. Overview of drug interactions with the quinolones.
Davey PG
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():97-107. PubMed ID: 3053579
[TBL] [Abstract][Full Text] [Related]
18. Overview of the pharmacokinetics of fleroxacin.
Nightingale CH
Am J Med; 1993 Mar; 94(3A):38S-43S. PubMed ID: 8452184
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and the fluoroquinolones.
Outman WR; Nightingale CH
Am J Med; 1989 Dec; 87(6C):37S-42S. PubMed ID: 2690618
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of quinolone antibiotics in rats: efflux from cerebrospinal fluid to the circulation.
Ooie T; Suzuki H; Terasaki T; Sugiyama Y
Pharm Res; 1996 Jul; 13(7):1065-8. PubMed ID: 8842046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
